)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
OnKure Therapeutics
OnKure Therapeutics (OKUR) investor relations material
OnKure Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary3 Jun, 2026
Opening remarks and agenda
Meeting called to order by the Chair, with introductions of directors, officers, and external representatives present.
Agenda included election of three Class II directors, ratification of the independent auditor, and amendment of the 2024 Equity Incentive Plan.
Board and executive committee updates
Board nominees for Class II directors were R. Michael Carruthers, Valerie M. Jansen, and Edward T. Mathers.
Board recommended votes in favor of all proposals presented.
Shareholder proposals
Proposals included electing three directors, ratifying KPMG as auditor, and amending the equity incentive plan to increase reserved shares by 8% and remove the annual share limit.
Explain the change to the Evergreen provision
Specify the 2024 reverse stock split ratio
List the Chief Medical and Scientific Officers
Explain the removal of the evergreen share limit
Identify the Class II directors elected in 2026
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from OnKure Therapeutics
- Q1 2026 net loss was $15.2M; $192.1M cash supports PI3Ka pipeline and operations into 2029.OKUR
Q1 20265 May 2026 - 36.1 million shares registered for resale after $150M private placement; financial risks remain.OKURRegistration filing24 Apr 2026
- Advancing best-in-class PI3Kα pan-mutant inhibitors for major oncology and rare disease markets.OKURCorporate presentation24 Apr 2026
- Key votes include director elections, auditor ratification, and equity plan amendments.OKURProxy filing22 Apr 2026
- Shareholders will vote on director elections, auditor ratification, and an expanded equity plan.OKURProxy filing22 Apr 2026
- Key clinical milestones and a strong cash position highlight progress in PI3Ka-targeted therapies.OKURQ4 202512 Mar 2026
- OKI-219 demonstrates high selectivity and tolerability, with key data expected later this year.OKURLeerink's Global Healthcare Conference 202526 Dec 2025
- Q1 2026 will bring pivotal OKI-219 data, driving expansion in triplet and pan-mutant programs.OKUREvercore ISI 8th Annual HealthCONx Conference13 Dec 2025
- OKI-219 demonstrates high selectivity and tolerability, with key combination trials ongoing.OKURStifel 2025 Virtual Targeted Oncology Forum25 Nov 2025
Next OnKure Therapeutics earnings date
Q2 202612 Aug, 2026
OnKure Therapeutics
Next OnKure Therapeutics earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage